Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 Oct;50(10):1331-6.
doi: 10.1136/jnnp.50.10.1331.

A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial

T Petersen  1 , J Jakobsen
Affiliations
Clinical Trial

A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial

T Petersen et al. J Neurol Neurosurg Psychiatry. 1987 Oct.

Abstract

In 25 neurological patients with detrusor hyperreflexia terodiline reduced the number of total micturitions during daytime. Bladder capacity was increased and amplitude of the bladder contractions was reduced. An increase in residual urine was also observed. Mild anticholinergic side-effects were measured on pupillary motility and on heart rate variation. It is concluded that terodiline is a useful alternative in treatment of patients with detrusor hyperreflexia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Urol Int. 1977;32(2-3):202-8 - PubMed
    1. Arch Neurol Psychiatry. 1950 Sep;64(3):341-77 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1978;43 Suppl 2:63-8 - PubMed
    1. Acta Neurol Scand. 1979 Sep;60(3):164-9 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1980;46 Suppl 1:20-30 - PubMed

Publication types